Instem to Present at Outsourcing Preclinical Development Conference, Berlin
Instem Presenting on SEND Status and Industry Deployment Plans
CONSHOHOCKEN, PA – November 27, 2013 - -Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Neil Donaldson, VP European and Asian Operations, Instem, will be presenting at the Outsourcing Preclinical Development Conference, Berlin, 3rd – 4th December.
The presentation, “The Impact of SEND on Outsourced Studies” will outline the status and industry deployment plans of the CDISC SEND (Standard for Exchange of Nonclinical Data) program and will discuss the implications of SEND for organizations that are outsourcing their preclinical studies, as well as outlining how companies can best prepare for these changes.
Mr. Donaldson said “Instem has been a leading participant in the SEND initiative from the outset and it is pleasing to see that the industry continues to actively embrace SEND. Numerous organizations are now utilizing Instem solutions to create and manage their SEND data sets.”
SEND defines the organization, structure, and format of standard nonclinical tabulation datasets for interchange between organizations such as sponsors and contract research organizations and for submission to the US Food and Drug Administration.
Instem is a key proponent of the SEND initiative and has been providing industry education and outreach to promote SEND while demonstrating its widely deployed technology solutions submit™ and SENDView™.
During 2012 Instem was recognized at the CDISC Interchange North America meeting for its outstanding contributions toward the completion of the SEND 3.0 Implementation Guide. In addition, earlier this year Instem received the VOLTAGE Technology Innovator Award for its submit-SEND solution at a ceremony in Philadelphia.
Outsourcing Preclinical Development is organized by Informa Life Sciences and is Europe’s only preclinical outsourcing event. “The Impact of SEND on Outsourced Studies” takes place at 11:50am on Wednesday 4th December in the Niche Innovation Emporium.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600